Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-11-08

Clinical Trial Update: Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer

View source ↗

Summary

The observational longitudinal study of pain in men with metastatic castration-resistant prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Status: WITHDRAWN